Sectors · Healthcare & Life Sciences

Biotech

Private financing across Biotech, aggregated from public sources.

Biotech is a subsector of Healthcare & Life Sciences. Zoom out to read the whole macro sector — $400.1B raised across 15,258 companies.

Biotechnology$155.0BOther Health Care$99.1BPharmaceuticals$60.1BHealthtech$51.9BHospitals and Physicians$12.7BPharma$8.8BBiotech / Pharma$5.7BMedical Devices$3.2B
$3.7B
Capital raised
233
Companies
199
Rounds
2009
First on record
2026-02-13
Latest round

Cooling Biotech drew $20.4M over the last 12 months, down 83% versus the prior 12 ($118.3M). Of 50 companies rankable against same-niche peers, 26% model over-valued and 18% under-valued.

Capital flow over time

Quarterly capital raised across Biotech.

2009-Q3 · $750K2009-Q32010-Q2 · $675K2010-Q4 · $2.4M2011-Q1 · $291K2011-Q4 · $1.4M2012-Q1 · $396K2012-Q12012-Q2 · $950K2012-Q3 · $6.2M2012-Q4 · $541K2013-Q2 · $400K2013-Q3 · $1.6M2013-Q32013-Q4 · $5.3M2014-Q1 · $7.2M2014-Q3 · $34.9M2014-Q4 · $5.7M2015-Q1 · $3.2M2015-Q12015-Q2 · $850K2015-Q3 · $1.4M2015-Q4 · $12.2M2016-Q1 · $5.1M2016-Q2 · $8.2M2016-Q22016-Q3 · $4.1M2016-Q4 · $67.3M2017-Q1 · $31.4M2017-Q2 · $2.2M2017-Q3 · $10.3M2017-Q32017-Q4 · $1.5M2018-Q1 · $37.4M2018-Q2 · $67.9M2018-Q3 · $13.0M2018-Q4 · $28.0M2018-Q42019-Q2 · $42.8M2019-Q3 · $6.2M2019-Q4 · $5.6M2020-Q1 · $11.2M2020-Q2 · $124.3M2020-Q22020-Q3 · $14.9M2020-Q4 · $32.2M2021-Q1 · $54.6M2021-Q2 · $221.9M2021-Q3 · $2.3B2021-Q32021-Q4 · $35.6M2022-Q1 · $35.7M2022-Q2 · $61.7M2022-Q3 · $4.3M2022-Q4 · $13.1M2022-Q42023-Q1 · $41.6M2023-Q2 · $35.7M2023-Q3 · $40.4M2023-Q4 · $29.4M2024-Q1 · $27.4M2024-Q12024-Q2 · $57.8M2024-Q3 · $49.6M2024-Q4 · $20.8M2025-Q1 · $31.9M2025-Q2 · $14.9M2025-Q22025-Q3 · $1.7M2025-Q4 · $4.8M2026-Q1 · $15.0M
Median round size by stage
StageMedian roundRounds
Growth/Late$2.2B1
Series D+$200.0M1
Series C$45.6M4
Series B$17.6M44
Series A$6.0M42
Seed$1.2M79
Pre-Seed$315K28
Top-funded companies
CompanyStageRaisedModeled value
Perkinelmer Inc
WALTHAM
Growth/Late$2.2B$65.2B
Nautilus Biotechnology, Inc.
San Carlos
Series D+$303.3M$6.0B
Arix Bioscience plc
LONDON
Series B$39.4M$850.9M
Watchmaker Genomics, Inc.
BOULDER
Series B$48.3M$712.8M
54Gene, Inc.
WASHINGTON
Series B$48.3M$598.4M
Lygos, Inc.
BERKELEY
Series B$41.7M$432.7M
hC Bioscience, Inc.
Cambridge
Series B$20.0M$430.6M
Montlake Bioscience Inc.
LAS VEGAS
Series A$11.3M$410.3M
Impact Genomics, Inc.
LA JOLLA
Series A$10.2M$369.3M
Synapticure, Inc.
CHICAGO
Series C$40.1M$332.6M
Transplant Genomics Inc.
Mansfield
Series A$20.6M$288.4M
Benchling, Inc.
SAN FRANCISCO
Series A$7.0M$253.2M
Epsilon3, Inc.
SANTA MONICA
Series A$15.0M$217.0M
Franklin BioScience - Penn LLC
DENVER
Series A$5.7M$204.6M
Trace Genomics, Inc.
Redwood City
Series B$45.3M$184.6M
Mytos, Inc.
NEWARK
Series B$18.0M$179.3M
ZBiotics Co
SAN FRANCISCO
Series B$28.1M$179.1M
Element Genomics, Inc.
DURHAM
Series A$4.8M$175.3M
Octave Bioscience Inc
MENLO PARK
Series B$105.8M$169.3M
Siren Biotechnology, Inc.
SAN FRANCISCO
Series B$19.6M$154.2M
Related sectors
Coal Mining$3.6BFood & Beverage$3.8BEnvironmental Services$3.8BEnergy / Climate$3.8BAirlines and Airports$3.4BPublic Safety & Security$3.4BEnergy Conservation$3.2BMedical Devices$3.2B

Browse all sectors or the full company rankings.

Frequently asked
How much venture funding has the Biotech sector raised?
Companies in Biotech have raised approximately $3.7B across 199 recorded financing rounds among 233 companies, aggregated from public sources.
Is Biotech venture funding growing?
Biotech funding is currently cooling: capital raised over the last 12 months was down 83% versus the prior 12 months.
What is the typical round size in Biotech?
Median disclosed round sizes in Biotech by stage are: Growth/Late $2.2B, Series D+ $200.0M, Series C $45.6M, Series B $17.6M. These are medians across recorded rounds, not averages.
Which are the most-funded Biotech companies?
The most-funded Biotech companies in our coverage include Perkinelmer Inc, Nautilus Biotechnology, Inc., Arix Bioscience plc, Watchmaker Genomics, Inc., 54Gene, Inc.. See the full ranked table for disclosed capital and modeled valuations.
When did Biotech funding activity begin in this data?
The earliest recorded Biotech financing in our coverage dates to 2009, with the most recent round around 2026-02-13.